|
 |
EprexThis page contains recent news articles, when available, and an overview of Eprex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Fast alle waren zuvor mit dem Präparat Eprex® (einige auch mit Epogen® oder NeoRecormon®) behandelt worden, die damals üblicherweise subkutan appliziert ... Deutsches Ärzteblatt Schon wieder Abbau bei der Cilag - Nov 3, 2009 Beispielsweise die Produktion des Medikaments Eprex, das man bisher teilweise bei einem Lohnhersteller hat produzieren lassen, sei im Lauf des Jahres nach ... Schaffhauser Nachrichten FDA cites Procrit, Eprex and Eopgen study - Sep 29, 2008 WASHINGTON, Sept. 29 (UPI) -- The US Food and Drug Administration issued an advisory about preliminary results of a German study involving the drug known as ... United Press International FDA probing deaths in J&J drug study - Sep 26, 2008 The study was testing if Eprex could improve brain function in stroke ... The patients were given either relatively high doses of Eprex for three days or a ... Reuters UK Biotech Drugs' Generic Future Debated - Feb 10, 2005 Eprex, experienced serious side effects after the company started using a new stabilizing chemical, and it took years to fully diagnose the problem. ... Washington Post EU approves Novartis generic anaemia drug - Aug 31, 2007 N)'s Eprex to win approval. More than 250000 patients in Europe are estimated ... Another two Eprex biosimilars, from Hexal -- also a Novartis unit -- and ... Reuters J&J reports anemia drug linked to deaths in study - Sep 17, 2008 Epoetin alfa is the chemical name for the Eprex brand sold by another Johnson & Johnson unit outside the United States. In this country, J&J sells it under ... USA Today California and the West; Bid to block Amgen drug discount fails; A... - Nov 23, 2006 Sales of Johnson & Johnson's Procrit, known in Europe as Eprex, were $2.5 billion. Aranesp and Procrit are both designed to treat anemia caused by the ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Shire undercuts rivals with launch of Dynepo drug - Mar 15, 2007 N) Erypo/Eprex, Amgen Inc's (AMGN.O) Aranesp and Roche Holding AG's (ROG.VX) NeoRecormon. Dynepo was approved for treating anaemia in patients with chronic ... Reuters Generic Anemia Drug Allowed - Sep 1, 2007 Novartis has become the first company to win approval for a copy of Johnson & Johnson's Eprex anemia treatment, allowing it to offer cheaper versions to ... New York Times Business | projo.com | The Providence Journal - Jul 21, 2006 Sales of Procrit, sold in Europe under the brand name Eprex, dipped 5 percent to $808 million in the quarter, J&J said earlier this week. ... Providence Journal S&P Picks and Pans: J&J, CBS, Morgan Stanley, Under Armour - Jul 31, 2007 Given approaching patent expirations for Risperdal and Topamax, and slower growth for Procrit/Eprex and drug-coated stents, we think J&J will increasingly ... BusinessWeek Anemia drug death link - Sep 18, 2008 Epoetin alfa is the chemical name for the Eprex brand sold by another Johnson & Johnson unit outside the United States. In the United States, ... Straits Times Bridling at Insulin's Cost, States Push for Generics - Jan 11, 2007 One cautionary tale about the sensitivity of biologic production involves Eprex, an anti-anemia drug Johnson & Johnson marketed in Europe. ... New York Times EPO discovered in Ballarat stable - Jun 30, 2007 Racing Victoria stewards, led by deputy chairman Terry Sharp, said the EPO was found in three vials of Eprex, an artificially produced form of the naturally ... Sydney Morning Herald The RADAR Project and the FDA—Reply - Sep 14, 2005 The FDA identified high rates of pure red cell aplasia with use of the epoetin alfa formulation Eprex, during the years 1998 to 2001. ... Journal of American Medical Association - Journal of American Medical Association... Trainers beat EPO charge - Dec 5, 2007 Stewards found that according to 1995 regulations, EPO, known as Eprex, could be sold wholesale to a vet solely for dispensary purposes and did not need to ... NEWS.com.au Strong Revenue Growth for J&J - Jan 22, 2008 ...$780 million consensus; Eprex/Procrit $628 million vs. $788 million consensus; Anti-psychotics $1.22 billion vs. $1.06 billion consensus. ... Briefing.com Increased warning for Aranesp.(Warnings)(Brief Article) - Mar 1, 2005 The update in the safety information is based on two studies with the erythropoietic products Eprex, comprising epoetin alfa, and NeoRecormon, ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones Warnings Sought for Procrit, Aranesp in Europe - Jun 27, 2008 All are made by Amgen, but Procrit – marketed as Eprex in Europe – is sold by Johnson & Johnson subsidiary Ortho Biotech under a licensing agreement. ... Newsinferno.com Three new 'biosimilars' to be launched in EU - Jun 26, 2007 A European regulatory committee has recommended the approval of three generic versions of Johnson & Johnson's (J&J) anaemia blockbuster Eprex in what could ... In-PharmaTechnologist.com Banned EPO Found In Ballarat Stables - Jun 29, 2007 The substance - branded as Eprex - was discovered during a stable inspection of the Dowling Forest stables used by Robert Smerdon, Tony Vasil, ... Racing and Sports Pty Ltd La saga Duquette se poursuit - Sep 13, 2006 L'Eprex est le nom d'une marque d'érythropoïétine vendue en France. Cette substance est interdite par le Comité international olympique et dans le monde du ... Radio-Canada Anti-anemia drugs for people with cancer or kidney failure under FDA ... - May 1, 2007 But the latest studies show that these injectable drugs, sold under the brand names of Aranesp, Procrit and Epogen (Eprex in Canada), increase the risk of ... Free with registration - HealthFacts - AccessMyLibrary.com Ciclismo | Dopaje La juez De Torres no quiso profundizar en este caso - May 26, 2006 92, bajo derecha, en Madrid", y añade que Eufemiano le dio allà "un vial de 10.000 unidades de EPO de la marca Eprex y 5 viales de EPO de 4.000 unidades ... AS Healthy Prognosis at Johnson & Johnson - Apr 18, 2007 Fools might be tempted to worry about challenging drug-eluting stent trends that are also hitting Boston Scientific (NYSE: BSX), Procrit/Eprex drug sales as ... fool.com Affaire Jeanson: le Dr Duquette coupable - Jul 14, 2005 En novembre 2003, le docteur Duquette a reconnu avoir administré de l'Eprex, une marque d'érythropoïétine (EPO), à la cycliste montréalaise Geneviève ... Radio-Canada ä¸é¢¨ç—…人æœ?貧血藥Eprex è¼ƒæ˜“æ» - Sep 27, 2008 ...ã€?æ˜Žå ±å°ˆè¨Šã€‘ç”±å¼·ç”Ÿï¼ˆJohnson & Johnson）出å“?ã€?å?«æœ‰ç´…細胞生æˆ?ç´ Epoetin alfa的貧血 è—¥Eprexï¼Œåœ¨ä¸€é …å¾·åœ‹ç ”ç©¶ä¸é¡¯ç¤ºï¼ŒæŽ¥å?—該藥治療的病人較易æ»äº¡ã€‚ ... 香港新浪網 Pre-operative injections of epoetin-[alpha] versus post-operative … - Aug 1, 2008 A total of 100 patients were randomly allocated to the Eprex (pre-operative ... In the Eprex group, 4% of the patients (two patients) received at least one ... Pay-Per-View - Journal of Bone and Joint Surgery - HighBeam Research At medical journals, paid writers play big role - Dec 13, 2005 A J&J unit had sponsored a study measuring whether Eprex patients could do well taking the drug only once a week. The company was facing competition ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Fitch Affirms Johnson & Johnson's Ratings. - Jun 8, 2007 While a few of JNJ's products (Duragesic, Eprex, Risperdal and Cypher) face challenges in the near-term, Fitch expects the company to deliver strong ... $4.95 - Business Wire - ECNext Aplasia pura de células rojas y tratamiento con eritropoyetina - Oct 5, 2005 Eprex, comercializado fuera de Estados Unidos, fue responsable del 92% de los casos. ... En 1998, la formulación de Eprex con albúmina sérica humana ... Intramed.net - Intramed.net (Suscripción) Novartis clears EU hurdle for generic biotech drug - Jun 22, 2007 BOSTON (MarketWatch) -- European regulators this week moved one step closer to approving Novartis AG's version of the blockbuster drug Eprex, known in the ... MarketWatch NO1.뉴미디어'마ì?´ë?°ì?¼ë¦¬ - Sep 27, 2008 ...존슨앤존슨사ì?˜ ë¹ˆí˜ˆì¹˜ë£Œì œ 'ì?´í”„ë ‰ìŠ¤(Eprex)'ë¡œ 치료를 ë°›ì?€ 사람들ì?˜ 사ë§?율ì?´ 높ì?€ 것ì?„ 나타나 미 FDAê°€ ì?´ì—? 대한 조사ì—? 착수한 것으로 나타났다. ... 마ì?´ë?°ì?¼ë¦¬ Péage de Villefranche: un athlète international marocain avec de l'EPO - Jan 12, 2005 ...ils ont trouvé dans un véhicule un sac contenant dix seringues d'EPO, deux flacons d'érythropoéïtine de marque Eprex, ainsi qu'une boîte d'Unatrope, ... Yabiladi A clinical review of antibody-mediated pure red cell aplasia.(Continui... - Jan 1, 2005 Shortly after a change in the formulation of the Eprex[R] brand of rHuEPO sold ... The change in formulation of Eprex[R] followed recommendations in the ... $4.95 - Nephrology Nursing Journal - ECNext … incidenza di mortalità dopo somministrazione di Eprex nei pazienti... - Dec 10, 2008 Mercoledì 10 Dicembre 2008 - L'FDA ( Food and Drug Administration ) è venuta a conoscenza di problemi di sicurezza con l'impiego di Epoetina alfa nei ... XagenaSalute Ny kontraindikasjon: Eprex skal ikke gis subkutant til pasienter med ... - Oct 20, 2007 Eprex (epoetin alfa) «Janssen Cilag» brukes blant annet for Ã¥ motvirke anemi hos pasienter med kronisk nyresvikt. Det er de siste Ã¥rene oppdaget tilfeller ... Statens legemiddelverk Anemia Da Insufficienza Renale Cronica - Medicina News - Jan 18, 2008 ...somministrato per via endovenosa ogni due settimane per 24 settimane, confrontando il medicinale con Epoetina alfa ( Eprex ) o beta ( NeoRecormon ). ... XagenaSalute 强生抗贫血è?¯æˆ–é?å°?æ?€æ??高患心血管疾病å?¯èƒ½ - Mar 23, 2007 2006年，Aranespå’ŒEpogenè?”æ‰‹åˆ›é€ äº†66亿美元的销é‡?——å? 安进公å?¸æ€»æ”¶å…¥çš„一å?Šï¼›è€Œå¼ºç”Ÿ çš„Procrit(在海外市场上的å??称为Eprex)则以31.8亿美元的收入，æˆ?为强生当年第二大 ... å?ƒé¾™ç½‘ 强生调å?‡2007年盈利预期 - Oct 16, 2007 ...该公å?¸è¿˜æŠ¥å‘Šï¼Œç¬¬ä¸‰å£åº¦è´«è¡€è?¯Procritå’ŒEprex销售é¢?下é™?至6.82亿美元，较去年å?ŒæœŸ å‡?å°‘15%。 è?¯å“?销售é¢?大幅下é™?ï¼ŒåŽŸå› æ˜¯æ¶ˆè´¹è€…å¯¹å…¶å®‰å…¨æ€§é—®é¢˜ä»?然心å˜ç–‘è™‘ï¼ŒåŠ ... 新浪网 Comment se procurer de l'EPO? - Sep 22, 2007 L'EPO est en effet vendue sous ordonnance au Canada pour traiter l'anémie et l'insuffisance rénale, sous les noms d'Eprex et d'Aranesp. ... Canoë Johnson & Johnson "neutral-weight" - Mar 12, 2007 März angekündigten Änderungen der Angaben zu den Nebenwirkungen des Anämie-Medikaments Procrit/Eprex hätten die Analysten ihre Prognosen für das ... AktienCheck Spaanse hondenbrokken geliefd in wielerpeloton - Jun 30, 2006 Intussen kun je met eprex [handelsnaam van epo] het gehalte van het achtergebleven bloed ... De aranesp, de opvolger van eprex, was makkelijk te traceren. ... NRC Handelsblad J&J 'concerned' as Sandoz gets biosimilar EU approval - Sep 4, 2007 Eprex is manufactured by Ortho Biologics and sold by Janssen-Cilag (both J&J subsidiaries). The drug is sold almost exclusively to the European and Canadian ... In-PharmaTechnologist.com J&J Boosts Guidance - Apr 19, 2005 Risperdal has supplanted Procrit/Eprex as J&J's best-selling drug. The first quarter was strong enough to encourage J&J to raise its full-year earnings ... TheStreet.com - TheStreet.com (subscription) L'FDA ha emesso un Public Health Advisory sui farmaci stimolanti l' … - Mar 20, 2007 I farmaci in questione cono Darbepoetina alfa ( Aranesp ) ed Epoetina alfa ( negli USA: Epogen e Procrit; in Italia: Eprex, Globuren ). ... XagenaSalute FDA warns over deaths in German epoetin alfa stroke trial; further... - Oct 6, 2008 Patients were randomized to either receive treatment with Eprex administered ... Furthermore, 4% of patients taking Eprex died from intacranial hemorrhage ... $9.94 - Pharma Marketletter - Alacra Store Press Release: Research and Markets: Key Process Patents for … - May 3, 2005 Article: Intravenous Administration Required When Using EPREX/ERPYO ... ... European labeling) for EPREX/ERYPO (epoetin alfa) to further ensure intravenous ... Pay-Per-View - PR Newswire - HighBeam Research Gensplejset medicin er mindre effektiv - May 29, 2007 »Med Eprex-sagen kan vi se, at med bioteknologisk produceret medicin kan selv smÃ¥ ... »Og i Danmark som i andre lande advarer vi nu mod at bruge Eprex ... Dagbladet Information SYNTHETIC HORMONE MAY INCREASE RISK IN KIDNEY PATIENTS.( … - Nov 16, 2006 The Cincinnati Post (Cincinnati, OH); July 20, 2002 ; 570 words ... ... drug Eprex is used in Europe and Canada to raise levels of red blood cells in people ... Pay-Per-View - Cincinnati Post - HighBeam Research Further delay in Smerdon, O'Sullivan EPO inquiry - Oct 10, 2007 It was also submitted that the Eprex in question had a use-by date of 1996/97. When adjourning the inquiry on Monday, steward Terry Sharp said, ... The Age Earnings Calls: Johnson & Johnson First Quarter Earnings Call - May 5, 2007 Matthew Dodds: How has PROCRIT/EPREX trended in first quarter and what trends do you ... Dominic Caruso: The major impact for PROCRIT/EPREX came from the ... 123Jump.com Edgewater graduate shot at college: Old Dominion guard Brandon … - Jan 27, 2006 16-month low Friday on reports that federal ... complaining to FDA inspectors. The plant is where Johnson & Johnson makes Eprex, a drug used to boost . ... Pay-Per-View - Orlando Sentinel - HighBeam Research Amgen Says 2nd-Quarter Profit Rose on Higher Aranesp Drug Sales - Jul 19, 2005 A setback for Johnson & Johnson in Europe, where Procrit is sold under the brand name Eprex, has added to Amgen's gains outside the US Eprex was linked to a ... Bloomberg The Orlando Sentinel, Fla., Tim Povtak column: Johnson quietly leads ... - Oct 22, 2006 The plant is where Johnson & Johnson makes Eprex, a drug used to boost red blood ... Following the initial report Friday in The New York Times, share prices ... Pay-Per-View - Orlando Sentinel - HighBeam Research Fickle formulations.(News) - Sep 1, 2007 After Eprex had been on the market for 10 years without incident, European authorities asked all biologic manufacturers to remove human products, ... $4.95 - Dermatology Times - ECNext Alert Issued on Anemia Drugs - Dec 2, 2005 Sales of Procrit, which is sold as Eprex in Europe, were $3.59 billion. ... Procrit/Eprex is Johnson & Johnson's second-biggest selling drug. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Greater caution on anemia drugs seen after deaths - Jan 26, 2007 N) rival drugs Eprex and Procrit, and Amgen's older Epogen, Aranesp's active ... Similarly, a European study of Eprex several years ago showed patients with ... Reuters Mehr Todesfälle bei Medikamenten-Test - Oct 1, 2008 Forscher wollten wissen, ob das Medikament Eprex die geistigen Fähigkeiten von ... Das in der Studie verwendete Präparat Eprex des Pharmaherstellers Johnson ... WELT ONLINE Studies Show Anemia Drugs May Harm Cancer Patients - Feb 27, 2007 Under license from Amgen, Johnson & Johnson sells Procrit in the United States and Eprex abroad, with combined sales last year of $3.2 billion. ... New York Times Greater caution on anemia drugs seen after deaths - Jan 29, 2007 Like Johnson & Johnson's rival drugs Eprex and Procrit, and Amgen's older ... Similarly, a European study of Eprex several years ago showed patients with ... Reuters European regulator starts safety review of anemia drugs - MarketWatch - Apr 27, 2007 It's also cooperating on a review of the Eprex drug made by Johnson & Johnson (NYSE:JNJ) . Eprex is known by the name Procrit in the United States. ... MarketWatch Doping im Spitzensport Hundefutter für das Peloton - Jul 17, 2006 Vielmehr könne man Eprex "ohne Risiko" in kleinen Dosen nehmen: "Wenn man es gut macht, hat man bei den Dopingkontrollen keinerlei Risiko, ... FAZ - Frankfurter Allgemeine Zeitung J&J to bring in new line of treatment for blood cancer - Jun 3, 2005 Eprex has several copies in the domestic market. But the J&J representative said that Velcade does not have local clones to contend with. ... Hindu Business Line Second hematopoietic SCT in patients with thalassemia recurrence … - Jun 23, 2008 During this phase, patients receive desferrioxamine, Neupogen, Eprex and hypertransfusion regimen in outpatient. Conditioning regimen includes BU/Busilvex, ... Nature.com Khas comes to Murugan's aid - Jun 16, 2008 Murugan is in need of medical treatment for haemodialysis, in particular Eprex injections. The Eprex injections cost RM7,000 yearly. ... Malaysia Star Article: Veteran stars are more than ready for fall TV. - The Orlando... - Aug 3, 2005 16-month low Friday on reports that federal ... complaining to FDA inspectors. The plant is where Johnson & Johnson makes Eprex, a drug used to boost . ... Pay-Per-View - Orlando Sentinel - HighBeam Research La saga du Dr Duquette tire à sa fin - Jul 28, 2007 L'Eprex est une érythro-poïétine (EPO) commercialisée en France, ... Parmi la dizaine qui a reçu de l'Eprex, on retrouvait la cycliste de Lachine, ... Canoë Safety Issues Specific to Clinical Development of Protein Therapeutics - May 12, 2008 21 Recent biophysical studies of two epoetin- products, Epogen (Amgen, Thousand Oaks, CA) and Eprex, revealed that the proteins are not identical, ... Nature.com BUSQUE EN LAS NOTICIAS DE SALUD - Sep 26, 2008 El estudio estaba comprobando si Eprex podÃa mejorar la función cerebral de los pacientes con ACV, ... Eprex se conoce genéricamente como epoetina alfa. ... Buena Salud J&J profits rise - Apr 15, 2008 Combined sales of anemia drugs Procrit and Eprex fell 23 percent to $629 million ... He sees overseas revenue of Eprex falling 10 percent to $1.1 billion. ... ReportonBusiness.com Hooters tour win huge for Orlando golfer. | Article from Orlando... - Mar 26, 2007 16-month low Friday on reports that federal ... complaining to FDA inspectors. The plant is where Johnson & Johnson makes Eprex, a drug used to boost . ... Pay-Per-View - Orlando Sentinel - HighBeam Research Johnson pulls off squeeze play for Nextel win. | Article from Orlando... - Mar 18, 2007 16-month low Friday on reports that federal ... complaining to FDA inspectors. The plant is where Johnson & Johnson makes Eprex, a drug used to boost . ... Pay-Per-View - Orlando Sentinel - HighBeam Research Doping in België Wie produceert? Wie levert? Wie 'pakt'? - Jul 7, 2005 Bij patiënten die langdurig het product Eprex onderhuids inspoten, viel de productie van rode ... Alle Eprex-verpakkingen werden van de markt gehaald, ... Trends-Tendances - Trends-Tendances Article: FRIENDSHIP THICKER THAN BLOOD; COLLEGE STUDENT … - Jan 4, 2007 For now, we've cleared the waiting list for Enbrel,'' said Rebecca ... a flurry of news surrounding Johnson & Johnson's anemia drug Eprex. ... Pay-Per-View - Post-Standard - HighBeam Research Die Kopisten stoßen an Grenzen - Mar 17, 2005 So verschärfte Eprex die Blutarmut, statt sie zu beheben. Angesichts dieser subtilen, aber folgenschweren Unschärfen sprechen Pharma-Experten inzwischen ... Spiegel Online Nuevos datos alertan sobre el uso de EPO para tratar la anemia - Mar 13, 2007 Con licencia de Amgen, Johnson & Johnson vende Procrit en Estados Unidos y Eprex en el extranjero, con ventas totales de 2.415 millones de euros anuales. ... El PaÃs - El PaÃs (España) Heart Risk Seen in Drug for Anemia - Nov 16, 2006 Johnson & Johnson, which sells epoetin under the brand names Procrit in the United States and Eprex everywhere else, reported sales of $2.4 billion in the ... New York Times FDA разбирает Ñ?лучаи Ñ?мертей в ходе клиничеÑ?кого иÑ?Ñ?ледованиÑ? - Oct 1, 2008 Целью иÑ?Ñ?ледованиÑ? было уÑ?тановить, может ли Eprex улучшить мозговую деÑ?тельноÑ?Ñ‚ÑŒ у пациентов, перенеÑ?ших инÑ?ульт, что не Ñ?влÑ?етÑ?Ñ? одобренным показанием к ... ФармацевтичеÑ?кий веÑ?тник J&J Ends Plan to Seek Wider Procrit Use - Sep 6, 2007 J&J also sells a different synthetic erythropoietin, Eprex, internationally. J&J sold $758 million of Procrit and Eprex in the quarter ended in June. Subscription - Wall Street Journal Online - Dow Jones & Company GPhA Rebuttal On Dr. Siegel's Comments At Hearing - Mar 13, 2007 Siegel's use of Eprex is both alarmist and incomplete. Changes in the formulation of Eprex were allowed in Europe, using then-European standards. ... Medical News Today - Medical News Today (press release) Roche anaemia drugs may have cheaper rivals soon - Dec 8, 2005 Arzneimittel AG access to a new stable of products, including copies of some bestsellers such as Roche's NeoRecormon and J&J's Eprex anemia treatments. ... Financial Express (JNJ) SqueezeTrigger Price is $62.442. There is $1,387,657,735.00... - Mar 4, 2008 Sales of the Company's two largest products, RISPERDAL and PROCRIT(R)/EPREX, accounted for approximately 6% and 7% of Johnson & Johnson's total revenues, ... Free with registration - M2 Presswire - AccessMyLibrary.com Therapeutic Proteins - Feb 1, 2005 5.3 Procrit/Eprex' Sales will Recover 5.4 Epogen - The Class Progenitor 5.5 Aranesp - The New EPO on the Block 5.6 NeoRecormon Will Be Unaffected by Patent ... MarketResearch.com Recession-Proof Stocks: Johnson & Johnson - Jun 27, 2008 Nearly 40% of sales come from the pharmaceutical unit and a stable of billion-dollar drug franchises such as Remicade, Procrit/Eprex, and Topamax. ... fool.com New Study by BioTrends Highlights Practice Management Shifts Among … - Nov 19, 2008 Satisfaction between brands is similar, but Eprex has a perceived competitive advantage on achieving target hemoglobin levels quickly and allowing for easy ... International Business Times Johnson & Johnson's earnings rise - Oct 17, 2006 But combined sales of anemia drugs Procrit and Eprex slumped 6 percent to $798 million, hurt by competition from newer products. ... msnbc.com Une chimiothérapie avec moins de transfusions - Mar 30, 2005 L'une de ces compagnies, Janssen-Ortho, fabrique l'Eprex et sa division canadienne a financé une étude sur son efficacité, dont la revue américaine The ... Agence Science-Presse Tout le monde le fait - May 30, 2008 Il avoue lui avoir «peut-être» à une occasion et à titre de test seulement donné 2000 unités d'Eprex car elle présentait de l'anémie. ... Canoë Onvrede over landelijke apotheken - Sep 5, 2006 Zo mogen de middelen epoëtine (Eprex, NeoRecormon) voor anemie als gevolg van chronische nierinsufficiëntie, gosereline (Zoladex) voor endometriose en ... Medisch Contact Press Release: New Study by BioTrends Highlights Practice Management … - Nov 19, 2008 Satisfaction between brands is similar, but Eprex has a perceived competitive advantage on achieving target hemoglobin levels quickly and allowing for easy ... Pay-Per-View - PR Newswire - HighBeam Research Amgen continues protecting its hold on biotech products. - Dec 12, 2005 Aranesp can be marketed for both uses in the US, but overseas it faces competition from Johnson & Johnson's Eprex and Hoffmann-LaRoche Inc.'s NeoRecormon. ... $4.95 - Los Angeles Business Journal - ECNext World healthcare: Key player - Johnson & Johnson - Dec 31, 2008 However, Procrit/Eprex, an anaemia treatment, is being undermined by competition and ... Meanwhile, Procrit/Eprex, once the company's best-selling drug, ... $34.00 - EIU Country Analysis - Alacra Store Amgen finds it's a new world after Vioxx deaths and verdict.( … - Sep 5, 2005 Three years ago, reports surfaced that Eprex, a version of Epogen licensed from Amgen by Johnson & Johnson and sold in Europe, was resulting in the death of ... $4.95 - Los Angeles Business Journal - ECNext (JNJ) SqueezeTrigger Price is $63.457. There is $948,271,368.75 That ... - Jul 16, 2007 Sales of the Company's two largest products, RISPERDAL and PROCRIT(R)/EPREX, accounted for approximately 6% and 7% of Johnson & Johnson's total revenues, ... $4.95 - M2 Presswire - ECNext FINAL TRANSCRIPT - May 5, 2008 ...and bio similars starting to impact that Eprex business outside the ... And finally, Eprex for Sub Q in chronic renal failure outside the United States. ... $54.00 - Thomson StreetEvents - Alacra Store Earnings: Yahoo, Sun Microsystems, AMD, More... - Jan 23, 2007 But combined sales of anemia drugs Procrit and Eprex slipped 1 percent to $788 million, hurt by longer-acting rival Aranesp sold by Amgen Inc. . ... FOXNews Panel Seeks New Limits on Anemia Drugs - Mar 14, 2008 Johnson & Johnson had sales of $2.9 billion last year for Procrit and Eprex, a similar drug sold outside the United States. Both are sold under license from ... New York Times Shares Of J&J Rise On News Employees To Depart - Jul 31, 2007 ..."Given approaching patent expirations for Risperdal and Topamax, and slower growth for Procrit/Eprex and drug-coated stents, we think JNJ will increasingly ... Forbes Erste Kopien von Biotech-Medikamenten drängen auf den Markt - Jun 26, 2006 In ähnlichen Höhen belaufen sich die Auslandsumsätze des EPO-Produkts Eprex von Johnson & Johnson. An diesem Kuchen wollen Generika-Hersteller auch ... biotechnologie.de A Herculean task - chasing drug cheats - Aug 8, 2008 He gets ripped off by paying R5 000 for a box of Eprex (EPO). He then goes and doses himself with something he knows nothing about. That's dangerous." ... Independent Online |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |